Researchers studying Alzheimer’s disease are using artificial intelligence-powered databases to accelerate the drug discovery process by making it easier to sift through vast amounts of biomedical ...

Biosimilars are essential healthcare equalizers, but their regulation is overly complicated due to lobbying by makers of ...

The battle against drug resistance in lung cancer therapy remains a critical issue in oncology, with resistance mechanisms ...

The FDA granted orphan drug designation to HLX22 for gastric cancer, advancing global phase 3 trials to improve first-line ...

Dr. Reddy’s Laboratories RDY and partner, Alvotech ALVO, announced the FDA’s acceptance of a regulatory filing, seeking the ...

Shanghai Henlius Biotech, Inc. (2696.HK) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for HLX22, the company's innovative anti-HER2 monoclonal ...

Global biosimilar regulatory harmonization will be needed to reduce development costs and improve patient access, despite ...

SEOUL: Celltrion, a major South Korean biopharmaceutical firm, said on Monday that its biosimilar for asthma and other chronic allergic diseases has obtained approval for sales in the US market. The ...

Regeneron Pharmaceuticals (NASDAQ:REGN) dropped 3% after the company's loss against Amgen (AMGN) and others in a patent case ...

Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...

Between 2005 and 2015, nearly three-fourths of issued drug patents were for already existing drugs. A common argument in ...

this year’s event will feature topics including applications of AI/ML within target identification and computational drug design, the impact of generative AI on ways of working and clinical updates ...